--The New England Journal of Medicine published favorable clinical trial data about Johnson & Johnson's potential Covid-19 vaccine, including data about safety and immune response, CNBC reported.
-- Dr. Paul Stoffels, the company's chief scientific officer, told CNBC that the results give the company confidence about its vaccine.
Full story: https://www.cnbc.com/2021/01/13/covid-vaccine-johnson-johnson-one-shot-safe-generates-immune-response.html?__source=newsletter%7Cbreakingnews
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
01-13-21 1735ET